ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 84 filers reported holding ORCHARD THERAPEUTICS PLC in Q1 2021. The put-call ratio across all filers is 3.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $64,000 | -19.0% | 110,366 | -0.9% | 0.00% | – |
| Q1 2022 | $79,000 | -44.0% | 111,347 | +4.6% | 0.00% | – |
| Q4 2021 | $141,000 | -62.4% | 106,442 | -34.7% | 0.00% | – |
| Q3 2021 | $375,000 | -16.9% | 162,948 | +58.5% | 0.00% | – |
| Q2 2021 | $451,000 | -70.5% | 102,832 | -51.2% | 0.00% | – |
| Q1 2021 | $1,530,000 | +78.5% | 210,740 | +6.3% | 0.00% | – |
| Q4 2020 | $857,000 | +21.6% | 198,317 | +15.6% | 0.00% | – |
| Q3 2020 | $705,000 | -41.7% | 171,547 | -14.9% | 0.00% | – |
| Q2 2020 | $1,210,000 | +111.5% | 201,609 | +165.6% | 0.00% | – |
| Q1 2020 | $572,000 | +2.3% | 75,899 | +86.7% | 0.00% | – |
| Q4 2019 | $559,000 | +44.8% | 40,653 | +25.1% | 0.00% | – |
| Q3 2019 | $386,000 | – | 32,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 4,081,972 | $9,388,000 | 2.74% |
| RA Capital Management | 11,028,722 | $25,366,000 | 0.35% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $15,984,000 | 0.31% |
| Avidity Partners Management LP | 3,836,798 | $8,825,000 | 0.20% |
| Casdin Capital, LLC | 2,575,000 | $5,923,000 | 0.15% |
| Vivo Capital, LLC | 1,325,736 | $3,049,000 | 0.14% |
| Artal Group S.A. | 1,803,858 | $4,149,000 | 0.09% |
| Eversept Partners, LP | 569,581 | $1,310,036 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 374,811 | $862,000 | 0.09% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,315 | $2,480,000 | 0.07% |